Key Companies Covered in the include Jubilant Life Sciences Limited (India), Charles River Laboratories (US), IBM (US), Clarivate Analytics (US), and Accenture (Ireland).

The Global Drug Discovery Informatics Market is projected to reach USD 6.5 billion in 2031 from USD 3.2 billion in 2022, at a CAGR of 10.3% during the forecast period 2022-2031. Kenneth Research, in its repository of market research reports, have recently added a report on Drug Discovery Informatics Market which emphasizes on the latest trends, key opportunities, drivers, and the challenges associated with the growth of the market during the forecast period, i.e., 2022-2031. The Drug Discovery Informatics Market is anticipated to grow primarily on account of the growing trade of ICT goods and services worldwide.

Request To Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10085962

In Q4 2021, U.S. current-account deficit widened stood at $224.8 billion. However, in Q1 22, CAD rose by 29.6%, reached to $291.4 billion, adding $66.6 billion to the gap. Export of good and services increased by $25.7 billion to reach $1.03 trillion in the first quarter of 2022. However, country’s goods and services deficit was $79.6 billion in June, down $5.3 billion from $84.9 billion in May, revised- reflecting some sight of relief. On the other hand, annual inflation rate in the country hit 8.5%. Energy CPI surged by 32.9% in July 2022, inflating the cost of logistic and signs to disrupt supply chain whilst electricity cost upsurged by 15.2%, highest since Feb 2006. Apart from that, In July 2022, existing US home sales declined 5.9% to 4.81 million (seasonally adjusted annual rate), the lowest since May of 2020 and below market expectations of 4.89 million. As mortgage rate touches highest at 6%, sales for houses declined for a sixth consecutive month. Global energy crises to remain at focal point impacting the economic activity in the U.S, pushing consumers to spend less on the products and services and save more.

On the other hand, the worst is expected to be seen in the European countries, especially during 2022 winters. The energy and gas crises has already started grappling the region, wherein many Western European countries including Germany is looking for coal fired solutions to tackle the gas supply shortage created by Russian-Ukraine conflict.

Amidst global concerns, market players have started looking for safe investments by holding on to the new technology and product launches. Factors like currency translation, disruption in global supply chain, Anti-China sentiments brewing across the globe, slowdown in Chinese economy, inflated products prices, USD getting stronger every week, decreasing purchasing power and strict measures taken by central banks/institutions across the world to ensure less spending and more saving, could hit the demand for the product and service badly in near future.

The Global Drug Discovery Informatics Market is projected to reach USD 6.5 billion in 2031 from USD 3.2 billion in 2022, at a CAGR of 10.3% during the forecast period 2022-2031 Drug discovery informatics is a functional process performed by biotechnology and pharmaceutical companies that requires the generation of very large data and information. Through application of modern engineering and computational approaches the models are analyzed, visualized and simulated for pharmacological profiling. Further, rising R&D expenditure on pharmaceuticals along with the increasing government focus on drug discovery are some key forces, driving the growth of the drug discovery informatics market over the forecast period of 2022-2031.

For instance: According to the U.K. government in 2016, drug development sector and continuous manufacturing would receive funds around USD 82.5 million from government and private sources as part of its new USD 188 million effort and ‘Industry Strategy’ to establish six key research hubs in UK to boost research and development activities related to drug discovery. As a result, the adoption of the drug discovery informatics would increase thereby, contributing towards the growth of the market. However, high pricing and set up cost of informatics software impede the growth of the global drug discover informatics market.

Major market player included in this report are:
Jubilant Life Sciences
IBM
Infosys
Thermo Fisher Scientific
Perkinelmer
Schrödinger
Dassault Systèmes
Charles River Laboratories
GVK Biosciences
Boehringer Ingelheim GmbH

The regional analysis of global drug discovery informatics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to well-established healthcare infrastructure along with the presence of various biotechnology and drug companies. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026 due to availability of low cost of human resources and manufacturing and availability of many qualified researchers. Also, the growth of the Asia-Pacific region is attributed owing to the ongoing drug development activities undertaken by government.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Function:

Sequencing & Target Data Analysis
Docking
Molecular Modelling
Libraries & Database Preparation
Other Functions

Enquire before purchasing this report – https://www.kennethresearch.com/sample-request-10085962

By Solution:

Software
Services

By End-User:

Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROS)
Others End Users

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Target Audience of the Global Voice Analytics in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Million)
1.3.1. Drug Discovery Informatics Market, by Function, 2016-2026 (USD Million)
1.3.2. Drug Discovery Informatics Market, by Solution , 2016-2026 (USD Million)
1.3.3. Drug Discovery Informatics Market, by End-user 2016-2026 (USD Million)
1.3.4. Drug Discovery Informatics Market, by Region, 2016-2026 (USD Million)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Drug Discovery Informatics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Drug Discovery Informatics Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Drug Discovery Informatics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion
Chapter 5. Global Drug Discovery Informatics Market, by Function
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Drug Discovery Informatics Market, Sub Segment Analysis
5.3.1. Sequencing & Target Data Analysis
5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.2. Docking
5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.3. Molecular Modelling
5.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
5.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.4. Libraries & Database Preparation
5.3.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
5.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.5. Other Functions

Request For Sample Report: https://www.kennethresearch.com/sample-request-10085962

About Kenneth Research

Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defence, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research, are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.

Contact Us

Kenneth Research
Email: [email protected]
Phone: +1 313 462 0609